Psoriasis: all 1,928 studies
Page 11 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- HB0034 in Patients With Generalized Pustular Psoriasis (GPP)CompletedNCT05512598Phase 1
- Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT05510063Phase 4
- Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With PsoriasisCompletedNCT05509361Phase 3
- Biofeedback for PsoriasisCompletedNCT05506644Not applicable
- A Study of AK111 in Subjects With Moderate-to-severe Plaque PsoriasisCompletedNCT05504317Phase 1
- Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic ArthritisWithdrawnNCT05499416Phase 4
- To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT05495568Phase 3
- Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque PsoriasisCompletedNCT05488990Phase 1/2
- Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
- Monitoring of Inflammatory ConditionsCompletedNCT05458531
- A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate PsoriasisCompletedNCT05453942Phase 1
- A Clinical Study of ICP-488 in Healthy Subjects and Patients With PsoriasisStatus unknownNCT05451199Phase 1
- Asking People With Psoriasis About Lifestyle and EatingCompletedNCT05448352
- A Study of HB0017 in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT05442788Phase 1
- Topical SGX302 for Mild-to-Moderate PsoriasisCompletedNCT05442190Phase 2
- To Evaluate the Mechanism of Jing Si Herbal Tea Liquid Packets and Traditional Western Medicine for PsoriasisStatus unknownNCT05436938Not applicable
- Evaluation of the Effect of Sulphur Mineral, Thermal Water on Skin Microbiome in Plaque Psoriasis, a Pilot StudyStatus unknownNCT05431959Not applicable
- Phase I Study of GN-037 Cream for PsoriasisCompletedNCT05428202Phase 1
- Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in PsoriasisStatus unknownNCT05427175Phase 4
- Fractional CO2 Laser Versus Pulsed Dye Laser in Nail PsoriasisStatus unknownNCT05415839Not applicable
- Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized PsoriasisStatus unknownNCT05408208Not applicable
- Intradermal Tozinameran for Patients With Immune-mediated Dermatologic DiseasesCompletedNCT05406908Phase 4
- Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients .Status unknownNCT05401006Phase 4
- Improving Disease SeverityCompletedNCT05391178Not applicable
- Impact of COVID 19 on Psoriasis PatientsStatus unknownNCT05381402
- Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis PatientsCompletedNCT05377944Phase 3
- An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data SourceCompletedNCT05368818
- Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT05344482
- Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple DosingCompletedNCT05344248Phase 1/2
- Safety and Efficacy of TLL018 in Patients With Plaque PsoriasisCompletedNCT05342428Phase 1
- Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685CompletedNCT05332704Phase 1
- Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination OintmentCompletedNCT05330936Early Phase 1
- Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate PsoriasisStatus unknownNCT05326659Not applicable
- Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)CompletedNCT05320159
- Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis.Status unknownNCT05311501Not applicable
- Chinese Medicine for Patients With PsoriasisCompletedNCT05295979Phase 2
- Excimer Light in PsoriasisCompletedNCT05283876Not applicable
- A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.CompletedNCT05282771Early Phase 1
- ATG5 as a Serum Marker of Autophagy in Psoriatic PatientStatus unknownNCT05279638
- Tunisian National Registry on PsoriasisCompletedNCT05258838
- Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisStatus unknownNCT05258331Phase 1
- Clinical Trial of Probiotic Supplementation in Psoriasis VulgarisStatus unknownNCT05254249Phase 1/2
- Levels of Pigment Epithelium-derived Factor in Patients With Psoriasis.Status unknownNCT05252741Not applicable
- A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or PsoriasisCompletedNCT05252533Phase 1
- A Phase III Study in Subjects With Mild to Moderate Psoriasis.Status unknownNCT05249972Phase 3
- Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPPCompletedNCT05215561
- Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus AcitretinCompletedNCT05203354Phase 4
- Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in AdultsCompletedNCT05203315Phase 3
- Cardiovascular Risk Predictors in Patients With PsoriasisCompletedNCT05200598
- Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR StudyActive, not recruitingNCT05185258Phase 4
- Plexin B2 Gene Expression and Polymorphisms in PsoriasisCompletedNCT05184348Phase 1
- A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque PsoriasisCompletedNCT05174598Phase 3
- Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French GuidelinesStatus unknownNCT05144165
- Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive ImagingStatus unknownNCT05135312Phase 4
- Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work ProductivityActive, not recruitingNCT05132231
- Lifestyle Modification in Psoriatic Patients With Fatty LiverStatus unknownNCT05125757Not applicable
- A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With PsoriasisCompletedNCT05120297Phase 3
- Dietary Perceptions and Practices in Chinese Psoriasis PatientsCompletedNCT05118425
- Effects of Tildrakizumab on Epigenetic AgeCompletedNCT05110313Phase 4
- A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype PsoriasisCompletedNCT05108766Phase 3
- Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of ScalpCompletedNCT05105139
- A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe PsoriasisCompletedNCT05096364Phase 2
- Laser Induced Changes to Innervation and Vascularisation of Psoriatic SkinCompletedNCT05079256Not applicable
- Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Plaque PsoriasisStatus unknownNCT05078567Not applicable
- Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic PatientsStatus unknownNCT05076812
- Study of Efficacy and Safety of Investigational Treatment in Patients With Nail PsoriasisStatus unknownNCT05072886Phase 1
- Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice ExperimentCompletedNCT05065762
- Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in AdultsStatus unknownNCT05064748Phase 4
- Validation of a Dermatology-Specific Treatment Satisfaction InstrumentActive, not recruitingNCT05056168
- A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseCompletedNCT05051943
- Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis.CompletedNCT05046899Not applicable
- Sequential Treatment of Psoriasis With Traditional Chinese and Western MedicineStatus unknownNCT05042635Not applicable
- A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering From Plaque Psoriasis Through Clinical Utility and Health Outcomes.Status unknownNCT05036889Not applicable
- MBCT for Psoriasis Patients With Anxiety and DepressionStatus unknownNCT05010044Not applicable
- A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT05003531Phase 2
- Predicting Medication Response for Autoimmune DiseaseTerminatedNCT04995783
- Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome.Status unknownNCT04994951Phase 2
- Informative Value of Determining the Level of NF-κB Translocation in Lymphocyte Populations in Children With PsoriasisCompletedNCT04989296Not applicable
- A Study of LY3361237 in Participants With PsoriasisCompletedNCT04975295Phase 1
- Topical Methotrexate Microemulsion in the Treatment of Plaque PsoriasisStatus unknownNCT04971239Phase 4
- Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque PsoriasisCompletedNCT04930042Phase 3
- Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaCompletedNCT04927195Phase 1
- A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04914429Phase 4
- A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type PsoriasisCompletedNCT04911751Phase 2
- Subjects Through the Application of the Mindera Kit Part 2Status unknownNCT04904315
- A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in ChinaCompletedNCT04894890
- Effect of Chronic Inflammation on Myocardial Perfusion and FunctionTerminatedNCT04870827
- Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977Active, not recruitingNCT04862286Phase 3
- Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound?TerminatedNCT04857476Not applicable
- A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)CompletedNCT04855721Phase 2
- Shortening Treatments Of Chronic Inflammatory ConditionsStatus unknownNCT04848649Not applicable
- Pleiotropic Role of TRPV1 in Psoriasis InflammationCompletedNCT04848194Not applicable
- Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy AdultsCompletedNCT04843631Phase 1
- Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous PsoriasisCompletedNCT04841187
- A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT04839328Phase 3
- Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque PsoriasisStatus unknownNCT04839016Phase 3
- Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy SubjectsCompletedNCT04837235Phase 1
- A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in JapanCompletedNCT04826536
- Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE StudyCompletedNCT04823247
- Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in TaiwanCompletedNCT04818385